Preclinical Evaluation of a Fluorine-18 (18F)-Labeled Phosphatidylinositol 3‑Kinase Inhibitor for Breast Cancer Imaging

Breast cancer is one of the commonest malignancies in women, especially in middle-aged and elderly women. Abnormal activation of the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKt/mTOR) pathway has been found to be involved in breast cancer proliferation. Pict...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Molecular pharmaceutics 2019-11, Vol.16 (11), p.4563-4571
Hauptverfasser:	Altine, Bouhari, Gai, Yongkang, Han, Na, Jiang, Yaqun, Ji, Hao, Fang, Hanyi, Niyonkuru, Alexandre, Bakari, Khamis Hassan, Rajab Arnous, Maher Mohamad, Liu, Qingyao, Zhang, Yongxue, Lan, Xiaoli
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!